[24] AKAZOME M, NOGUCHI M, TANAKA O, et al. Enantiomeric recognition of alkyl phenyl sulfoxides by crystalline (R)-phenylglycyl-(R)-phenylglycine[J].Tetrahedron,1997,53:8315-8322.

[25] BORTOLINI O,FANTIN G,FOGAGNOLO M,et resolution of sulfoxides by inclusion in host dehydrocholic acid[J]. Chemical Communications,2000(5):365-366.

[26] KLUSSMANN M, IZUMI T, WHITE A J P, et al. Emergence of solution-phase homochiralityviacrystal engineering of amino acids[J].Journal of the American Chemical Society,2007,129:7657-7660.

[27] IWAMA S, KUYAMA K, MORI Y, et al. Highly efficient chiral resolution of DL-arginine by cocrystal formation followed by recrystallization under preferential-enrichment conditions[J].Chemistry:A European Journal,2014,20:-.

[28] GONNADE R G, IWAMA S, MORI Y, et al. Observation of efficient preferential enrichment phenomenon for a cocrystal of (DL) -phenylalanine and fumaric acid under nonequilibrium crystallization conditions[J].Crystal Growth&Design,2011,11:607-615.

[29] MANOJ K, TAKAHASHI H, MORITA Y, et al. Preferential enrichment of DL-leucine using cocrystal formation with oxalic acid under nonequilibrium crystallization conditions [J]. Chirality, 2015,27:405-410.

[30] SCOTT J L, HACHIKEN S, TANAKA K. Efficient isomeric enrichment in cocrystals of cyclohexanediamines and low molecular weight diols[J].Crystal Growth&Design,2008,8:2447-2452.

[31] ROY B N, SINGH G P, SRIVASTAVA D, et al. A novel method for large-scale synthesis of lamivudine through cocrystal formation of racemic lamivudine with (S)-(-)-1,1’-bi(2-naphthol) [(S)-(BINOL)][J].Organic Process Research&Development,2009,13(3):450-455.

[32] SáNCHEZ-GUADARRAMA O, MENDOZA-NAVARRO F,CEDILLO-CRUZ A, et al. Chiral resolution of RS-praziquantelviadiastereomericco-crystal pair formation with Lmalic acid[J]. Crystal Growth&Design,2016,16:307-314

[33] HARMSEN B, LEYSSENS T. Enabling enantiopurity: combining racemization and dual-drug cocrystal resolution[J]. Crystal Growth &Design,2018,18,3654-3660.

[34] HARMSEN B, LEYSSENS T. Dual-drug chiral resolution:enantiospecific cocrystallization of (S)-ibuprofen using levetiracetam[J].Crystal Growth&Design,2018,18:441-448.

[35] HE L C, LIANG Z R, YU G J. Green and efficient resolution of racemic ofloxacin using tartaric acid derivatives XT forming cocrystal in aqueous solution[J].Crystal Growth&Design,2018,18:5008-5020.

[36] SPRINGUEL G, ROBEYNS K, NORBERG B, et al. Cocrystal formation between chiral compounds: how cocrystals differ from salts[J].Crystal Growth&Design,2014,14:3996-4004.

[37] GEORGE F, TUMANOV N, NORBERG B, et al. Does chirality influence the tendency toward cocrystal formation?[J]. Crystal Growth&Design,2014,14(6):2880-2892.

[38] EDDLESTON M D,ARHANGELSKIS M,FRI??I? T,et al.Solid state grinding as a tool to aid enantiomeric resolution by cocrystallisation[J].Chemical Communications,2012,48:-.

[39] WANG N, HUANG X, GONG H, et al. Thermodynamic mechanism of selective cocrystallization explored by MD simulation and phase diagram analysis[J].AIChE Journal,2019,65(5):e.

文章来源：《中国药物经济学》 网址: http://www.zgywjjx.cn/qikandaodu/2021/0503/822.html